Skip to main content

Year: 2021

Three Valley Copper Increases its Ownership in MTV to 95.1%

(all amounts expressed in US dollars) TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) — (TSXV: TVC) – Three Valley Copper Corp. (“TVC” or the “Company”) today announces that its ownership of Minera Tres Valles SpA (“MTV”) has increased to 95.1% from 91.1%. On November 25, 2021, the Company announced the closing of a bought-deal financing (the “Financing”) to help support the operations of MTV. In accordance with the MTV shareholders agreement (the “SHA”), the minority shareholder of MTV (the “Minority Shareholder”) and SRH Chile SpA (an indirect, wholly-owned subsidiary of TVC) were provided the opportunity to subscribe for newly issued shares of MTV. The Minority Shareholder did not participate resulting in the dilution of their MTV ownership from 8.9% to 4.9% as per the terms of the SHA. Approximately $9 million of the Financing was...

Continue reading

Decibel Therapeutics Announces Appointments of Alison Finger, MBA and Saraswathy Nochur, Ph.D. to its Board of Directors; Christine Poon Steps Down from Board

BOSTON, Dec. 06, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the appointments of Alison Finger, MBA and Saraswathy (“Sara”) Nochur, Ph.D. to its Board of Directors. “I am thrilled to welcome Alison and Sara to the Decibel Board. Both bring a wealth of biopharma experience that is very relevant to Decibel’s trajectory and anticipated growth,” said Laurence Reid, Ph.D., Chief Executive Officer of Decibel. “Our Board of Directors is focused on helping guide our long-term strategy to build a leading biotech company that will change the therapeutic options for people with severe forms of hearing and balance disorders. The appointments of Alison and Sara...

Continue reading

SL Green Announces Sale of 25 Percent Interest in One Madison Avenue

NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE:SLG), Manhattan’s largest office landlord, today announced that it has sold a 25 percent interest in One Madison Avenue to an international investor. The buyer has committed aggregate equity to the project totaling no less than $259.3 million. SL Green retained a 25.5 percent interest in the property, while its joint venture partners, the National Pension Service of Korea and Hines, retained their 49.5 percent interest in the property. SL Green Realty Corp. and Hines are co-developing the $2.3 billion project. This transaction follows the successful signing of Chelsea Piers Fitness in October as the flagship retail tenant at the building. The development of One Madison Avenue, which is currently ahead of schedule and under budget, is transforming the existing...

Continue reading

Minim Strengthens Technology Leadership, Adds Two Engineering VPs from CommScope and Charles Schwab

MANCHESTER, NH, Dec. 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Minim, Inc. (NASDAQ: MINM), the creator of intelligent networking products under the globally recognized Motorola brand, today welcomes two technology leaders to its team: Bill Wallace joins Minim as Vice President, Hardware Engineering from CommScope, and Lakshmi Kadiyala joins as Vice President, Software Engineering from Charles Schwab. The team additions will join Alec Rooney, CTO of Minim, as the company pursues increased profitability through the introduction of advanced software-driven products in the coming year.  “I am thrilled to welcome both Bill and Lakshmi to the team,” said Gray Chynoweth, CEO of Minim. “The global market for intelligent connectivity products is massive, growing, and competitive. As such, we believe that to continue to win and delight...

Continue reading

Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions

LEXINGTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, small-molecule approach to treating inflammatory conditions and diseases by selectively targeting the resident microbiome to restore gut-immune homeostasis, today announced the extension and expansion of its research collaboration with Janssen Biotech, Inc. (“Janssen”). The collaboration is designed to explore the potential for Microbiome Metabolic Therapies (MMT™) to prevent childhood-onset of atopic, immune and metabolic conditions by promoting healthy function of the gut microbiome. Since the beginning of the collaboration, Kaleido’s proprietary ex vivo screening platform has identified several potential MMTs that support the growth of specific beneficial microbes in the gut microbiome...

Continue reading

Arena Minerals Announces Increased Investment by Lithium Americas and Appointment of Board Nominee

TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Arena Minerals Inc. (“Arena” or the “Company”) (TSX-V: AN) is pleased to announce the increased investment by Lithium Americas Corp. (NYSE: LAC) from approximately 12% to 17.5% of the issued and outstanding common shares of Arena. Please see press release ‘Lithium Americas increases strategic interest in Arena Minerals’ for further details. Lithium Americas has elected to exercise its right to appoint a member to the Board of Directors of Arena. Lithium Americas has nominated Mr. Ignacio Celorrio to join the Board. Mr. Celorrio is currently President, Latin America for Lithium Americas. Ignacio Celorrio, on behalf of Lithium Americas, commented, “Lithium Americas’ commitment to Argentina, and the Salta province, is represented in both our investment in Arena and...

Continue reading

Digital Ally Authorizes Stock Buy-Back Program for up to $10.0 Million of Common Stock

Digital Ally also Reaffirms its Revenue Guidance for Fourth Quarter 2021 and Fiscal 2022 Lenexa, KS, Dec. 06, 2021 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), which develops, manufactures, and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety, and security for venues and events, today announced that its Board of Board of Directors has approved a stock buy-back program authorizing the Company to purchase up to $10.0 million of the Company’s outstanding common stock subject to SEC regulations, stock market conditions and corporate working capital needs. The buy-back program will commence immediately with a duration of the program through December 31, 2022. Under the authorization provided by the Board, stock repurchases may...

Continue reading

Avicanna Files a Patent to Protect its Advanced Oral Cannabinoid Platform and its Applications for Neurological Diseases

Proprietary formulations include a range of liquids, capsules, powders, and controlled release tablets utilizing Avicanna’s self-emulsifying drug delivery systems (SEDDS) technology The advanced formulations offer enhanced stability, bioavailability and controlled release of cannabinoids including (CBD, THC, CBG, CBN and THCv) Avicanna intends to utilize the technology in its medical and pharmaceutical products and develop these formulations for treatment of neurological diseases and disorders TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based pharmaceuticals is pleased to announce that it has filed a provisional patent application...

Continue reading

CloudMD Graduates to the OTCQX; Begins Trading Today Under “DOCRF”

VANCOUVER, British Columbia, Dec. 06, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology company transforming the delivery of care, is pleased to announce that it has qualified to trade on the OTCQX® Best Market. CloudMD begins trading today on OTCQX under the symbol “DOCRF”. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize...

Continue reading

ECMOHO Limited Announces the Appointment of independent director of the Board

SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), an integrated solutions provider in the health and wellness market in China, today announced a change in its board of directors (the “Board”). Mr. Greg Ye tendered to the Board his resignation as an independent director of the Board, the chair and a member of the audit committee of the Board and a member of the Nominating and Corporate Governance Committee of the Board for personal reasons, effective from December 1, 2021. Mr. Greg Ye’s resignation did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practice. The Board appointed Mr. Yuan Fang as an independent director of the Board, the chair and a member of the Audit Committee of the Board and a member of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.